Dinkelbach, Lars
Peters, Triinu
Grasemann, Corinna
Hebebrand, Johannes
Hinney, Anke
Hirtz, Raphael
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 15 September 2023
Accepted: 15 March 2024
First Online: 27 March 2024
Declarations
:
: JH declares that he will be named as an inventor in a patent application that the University of Duisburg-Essen (UDE) prepares to file on the use of leptin analogues for the treatment of depression. He is also named as an inventor in a patent application filed by the UDE for use of metreleptin in Anorexia nervosa. JH received a speaker’s honorarium from Amryt Pharmaceuticals in 2021. LD, TP, AH, and CG have nothing to disclose.